http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107722014-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0152623cff45c7c58e9c47b65ea4ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02
filingDate 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ad82ff5f7e7a409ddb4cd889f40abc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57b6bf06dd0a0ae63b63c3dc4f5109f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e733720fb958df3863e9425f3348a98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f347195b7948c0f0e5ddc09f49232f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e58cea88846c58e26ed7ece8ee4ddb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5aff92f26b6827b2df4d2b6df63862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0040827c86e4b7cc5c295c03b895cfdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7837bb7cc3da033f29d598341ebd68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58f102596382064a14fa05b3955d763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11e0e67456f1094530d822a330b28eb4
publicationDate 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107722014-A
titleOfInvention Salts as Hepatitis C Virus Inhibitors
abstract The present invention relates to salts of compounds represented by formula (I) and pharmaceutical compositions thereof, specifically to base addition salts, acid addition salts and pharmaceutical compositions of compounds represented by formula (I), and further to said compounds or said compounds The use of the pharmaceutical composition in the preparation of medicines, especially the use in the preparation of medicines for preventing, treating, treating or alleviating hepatitis C virus (HCV) infection.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110117287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110117287-B
priorityDate 2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101580535-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105884779-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010088394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012040242-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22263119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421969768

Total number of triples: 39.